STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1

BRCA1, a multi-domain protein, is mutated in a large percentage of hereditary breast and ovarian cancers. BRCA1 is most often mutated in three domains or regions: the N-terminal RING domain, exons 11–13, and the BRCT domain. The BRCA1 RING domain is responsible for the E3 ubiquitin ligase activity o...

Full description

Bibliographic Details
Main Authors: Serena L. Clark, Ana M. Rodriguez, Russell R. Snyder, Gary D.V. Hankins, Darren Boehning
Format: Article
Language:English
Published: Elsevier 2012-04-01
Series:Computational and Structural Biotechnology Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2001037014601070
_version_ 1828849138643501056
author Serena L. Clark
Ana M. Rodriguez
Russell R. Snyder
Gary D.V. Hankins
Darren Boehning
author_facet Serena L. Clark
Ana M. Rodriguez
Russell R. Snyder
Gary D.V. Hankins
Darren Boehning
author_sort Serena L. Clark
collection DOAJ
description BRCA1, a multi-domain protein, is mutated in a large percentage of hereditary breast and ovarian cancers. BRCA1 is most often mutated in three domains or regions: the N-terminal RING domain, exons 11–13, and the BRCT domain. The BRCA1 RING domain is responsible for the E3 ubiquitin ligase activity of BRCA1 and mediates interactions between BRCA1 and other proteins. BRCA1 ubiquitinates several proteins with various functions. The BRCA1 BRCT domain binds to phosphoproteins with specific sequences recognized by both BRCA1 and ATM/ATR kinases. Structural studies of the RING and BRCT domains have revealed the molecular basis by which cancer causing mutations impact the functions of BRCA1. While no structural data is available for the amino acids encoded by exons 11–13, multiple binding sites and functional domains exist in this region. Many mutations in exons 11–13 have deleterious effects on the function of these domains. In this mini-review, we examine the structure-function relationships of the BRCA1 protein and the relevance to cancer progression.
first_indexed 2024-12-12T22:45:42Z
format Article
id doaj.art-aa36e5c73f5f4efcac4069d50f9aa04f
institution Directory Open Access Journal
issn 2001-0370
language English
last_indexed 2024-12-12T22:45:42Z
publishDate 2012-04-01
publisher Elsevier
record_format Article
series Computational and Structural Biotechnology Journal
spelling doaj.art-aa36e5c73f5f4efcac4069d50f9aa04f2022-12-22T00:09:13ZengElsevierComputational and Structural Biotechnology Journal2001-03702012-04-011110.5936/csbj.201204005STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1Serena L. Clark0Ana M. Rodriguez1Russell R. Snyder2Gary D.V. Hankins3Darren Boehning4Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX, 77550Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX, 77550Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX, 77550Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX, 77550Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX, 77550BRCA1, a multi-domain protein, is mutated in a large percentage of hereditary breast and ovarian cancers. BRCA1 is most often mutated in three domains or regions: the N-terminal RING domain, exons 11–13, and the BRCT domain. The BRCA1 RING domain is responsible for the E3 ubiquitin ligase activity of BRCA1 and mediates interactions between BRCA1 and other proteins. BRCA1 ubiquitinates several proteins with various functions. The BRCA1 BRCT domain binds to phosphoproteins with specific sequences recognized by both BRCA1 and ATM/ATR kinases. Structural studies of the RING and BRCT domains have revealed the molecular basis by which cancer causing mutations impact the functions of BRCA1. While no structural data is available for the amino acids encoded by exons 11–13, multiple binding sites and functional domains exist in this region. Many mutations in exons 11–13 have deleterious effects on the function of these domains. In this mini-review, we examine the structure-function relationships of the BRCA1 protein and the relevance to cancer progression.http://www.sciencedirect.com/science/article/pii/S2001037014601070ApoptosisBcl-2BaxBH3 domainApaf-1Apoptosome
spellingShingle Serena L. Clark
Ana M. Rodriguez
Russell R. Snyder
Gary D.V. Hankins
Darren Boehning
STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1
Computational and Structural Biotechnology Journal
Apoptosis
Bcl-2
Bax
BH3 domain
Apaf-1
Apoptosome
title STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1
title_full STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1
title_fullStr STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1
title_full_unstemmed STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1
title_short STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1
title_sort structure function of the tumor suppressor brca1
topic Apoptosis
Bcl-2
Bax
BH3 domain
Apaf-1
Apoptosome
url http://www.sciencedirect.com/science/article/pii/S2001037014601070
work_keys_str_mv AT serenalclark structurefunctionofthetumorsuppressorbrca1
AT anamrodriguez structurefunctionofthetumorsuppressorbrca1
AT russellrsnyder structurefunctionofthetumorsuppressorbrca1
AT garydvhankins structurefunctionofthetumorsuppressorbrca1
AT darrenboehning structurefunctionofthetumorsuppressorbrca1